Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Debt Ratio (2016 - 2022)

Lexaria Bioscience's Debt Ratio history spans 8 years, with the latest figure at 0.0 for Q2 2022.

  • For Q2 2022, Debt Ratio rose 589.24% year-over-year to 0.0; the TTM value through May 2022 reached 0.0, up 589.24%, while the annual FY2021 figure was 0.0, 94.49% down from the prior year.
  • Debt Ratio for Q2 2022 was 0.0 at Lexaria Bioscience, up from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.05 in Q4 2020 and bottomed at 0.0 in Q2 2021.
  • The 5-year median for Debt Ratio is 0.0 (2018), against an average of 0.01.
  • The largest annual shift saw Debt Ratio plummeted 99.39% in 2018 before it skyrocketed 2164.18% in 2021.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2018, then soared by 121.72% to 0.01 in 2019, then skyrocketed by 300.74% to 0.05 in 2020, then crashed by 98.9% to 0.0 in 2021, then surged by 44.82% to 0.0 in 2022.
  • Per Business Quant, the three most recent readings for LEXX's Debt Ratio are 0.0 (Q2 2022), 0.0 (Q1 2022), and 0.0 (Q3 2021).